Global /China /Healthcare /Medical Devices /688468

Chemclin Diagnostics Co., Ltd.

688468

• SSE: 688468 • Delayed

7.49CNY 1.1%

1.11 USD

As of 15 June 2026, Chemclin Diagnostics Co., Ltd. has a market cap of $431.51M USD, ranking #16157 globally and #5066 in China. It ranks #1453 in the Healthcare sector, and #307 in the Medical Devices industry.

Global Rank

16157

Country Rank

5066

Sector Rank

1453

Industry Rank

307

Key Stats

Market Cap

$431.51MUSD

2.92B CNY

Enterprise Value

$406.18MUSD

2.75B CNY

Revenue (TTM)

$49.1MUSD

332.68M CNY

EBITDA (TTM)

$13.82MUSD

93.49M CNY

Net Income (TTM)

$6.48MUSD

43.91M CNY

EBITDA Margin

28%

Profit Margin

13%

PE Ratio

67.4

PS Ratio

8.8

PB Ratio

2.1

EV/EBITDA

26.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Devices

CEO

Lin Li open_in_new

Employees

606

Founded

2007

Website

chemclin.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.1%	1.9%	1.1%	-8.2%	-5.7%	1%	6.9%	-32%	-72%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688468 科美诊断技术股份有限公司 Class A ISIN: CNE100005311 Shares Out.: Shares Outstanding: 394.593M¹ Shares Float: 394.567M² TV: TradingView: SSE: 688468 SA: Stock Analysis: SHA: 688468 YF: Yahoo Finance: 688468.SS GF: Google Finance: SHA: 688468 BA: Barron's: 688468 MS: Morningstar: XSHG: 688468	7.49 CNY	TV: TradingView: SSE: 688468 SA: Stock Analysis: SHA: 688468 YF: Yahoo Finance: 688468.SS GF: Google Finance: SHA: 688468 BA: Barron's: 688468 MS: Morningstar: XSHG: 688468

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Chemclin Diagnostics Co., Ltd.

Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments. Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A, hepatitis E, etc.; and detection of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation. The company was founded in 2007 and is headquartered in Beijing, China.

Similar Companies

Industry: Medical Devices (China)

Name	Market Cap (USD) diff.	PE	Country
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 7K%	26.0	China
Shanghai United Imaging Healthcare Co., Ltd. SSE: 688271	$13.61B 92.23B CNY 3K%	48.5	China
Shenzhen New Industries Biomedical Engineering Co., Ltd. SHE: 300832	$5.61B 38.02B CNY 1K%	23.4	China
Intco Medical Technology Co., Ltd. SHE: 300677	$5.52B 37.43B CNY 1K%	52.7	China
APT Medical Inc. SSE: 688617	$5.04B 34.14B CNY 1K%	39.6	China
Andon Health Co., Ltd. SHE: 002432	$4.55B 30.86B CNY 955%	13.7	China

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 40K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 37K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 37K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 29K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 28K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 24K%	22.2	Ireland

chevron_leftBack